- Home
-
Press releases
-
Media academy
- Lung Cancer
- Breast Cancer
- Ovarian Cancer
- Head & Neck Cancer
- Targeted Therapy
Boehringer Ingelheim
An A-Z glossary of cancer terms compiled by Boehringer Ingelheim to help you understand the terminology around cancer research and cancer treatments.
Each term in the glossary can also be found at the bottom of most pages on this website, including the home page.
Source for healthcare professionals: www.inoncology.com
* Nintedanib (BIBF 1120), afatinib (BIBW 2992) and volasertib (BI 6727) are investigational compounds. Their safety and efficacy have not yet been fully established.
